Michel Bottlaender

8.2k total citations · 1 hit paper
193 papers, 5.4k citations indexed

About

Michel Bottlaender is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michel Bottlaender has authored 193 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 63 papers in Cellular and Molecular Neuroscience and 55 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michel Bottlaender's work include Neuroscience and Neuropharmacology Research (48 papers), Medical Imaging Techniques and Applications (31 papers) and Nicotinic Acetylcholine Receptors Study (30 papers). Michel Bottlaender is often cited by papers focused on Neuroscience and Neuropharmacology Research (48 papers), Medical Imaging Techniques and Applications (31 papers) and Nicotinic Acetylcholine Receptors Study (30 papers). Michel Bottlaender collaborates with scholars based in France, United States and United Kingdom. Michel Bottlaender's co-authors include Héric Valette, Frédéric Dollé, Marie Sarazin, Christine Coulon, Julien Lagarde, Bruno Stankoff, Frédéric Dollé, Benedetta Bodini, Chantal Fuseau and Bruno Dubois and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Neuron.

In The Last Decade

Michel Bottlaender

186 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early and protective microglial activation in Alzheimer’s disease: a prospective study using¹⁸F-DPA-714 PET imaging

2016 374 citations Lorraine Hamelin, Julien Lagarde et al. profile →

Peers

Countries citing papers authored by Michel Bottlaender

Since Specialization

Citations

This map shows the geographic impact of Michel Bottlaender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Bottlaender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Bottlaender more than expected).

Fields of papers citing papers by Michel Bottlaender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Bottlaender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Bottlaender. The network helps show where Michel Bottlaender may publish in the future.

Co-authorship network of co-authors of Michel Bottlaender

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Bottlaender. A scholar is included among the top collaborators of Michel Bottlaender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Bottlaender. Michel Bottlaender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imaging the impact of sex and age on OATP function in humans: Consequences for whole-body pharmacokinetics and liver exposure 2025 ·Acta Pharmaceutica Sinica B ·Solène Marie, Anne-Lise Lecoq, (unknown), Fabien Caillé, Vincent Lebon, Claude Comtat, Sébastien Goutal, Laurent Becquemont, Michel Bottlaender, Céline Verstuyft, Nicolas Tournier	0
2	Effects of intravascular administration of mesenchymal stromal cells derived from Wharton’s Jelly of the umbilical cord on systemic immunomodulation and neuroinflammation after traumatic brain injury (TRAUMACELL): study protocol for a multicentre randomised controlled trial 2024 ·BMJ Open ·Stéphanie Sigaut, Coralie Tardivon, Alice Jacquens, Michel Bottlaender, Philippe Gervais, Marie‐Odile Habert, Antoine Monsel, Antoine Roquilly, Mathieu Boutonnet, (unknown), Audrey Cras, (unknown), (unknown), (unknown), Philippe Menasché, Vincent Degos, Camille Couffignal	0
3	Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls 2024 ·EJNMMI Research ·(unknown), Benedetta Bodini, (unknown), Mattia Veronese, Michel Bottlaender, Mattéo Tonietto, Bruno Stankoff	0
4	The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer’s disease 2024 ·Nature Aging ·Marie Sarazin, Julien Lagarde, (unknown), Leonardo Cruz de Souza, Bertrand Bellier, Marie‐Claude Potier, Michel Bottlaender, Guillaume Dorothée	16
5	The microglial translocator protein (TSPO) in Alzheimer’s disease reflects a phagocytic phenotype 2024 ·Acta Neuropathologica ·(unknown), (unknown), (unknown), Thomas F. Scott, (unknown), Michel Bottlaender, James A. R. Nicoll, Delphine Boche	9
6	In vivo imaging of the human brain with the Iseult 11.7-T MRI scanner 2024 ·Nature Methods ·Nicolas Boulant, Franck Mauconduit, (unknown), Alexis Amadon, (unknown), Michel Luong, Aurélien Massire, Christophe Pallier, Laure Sabatier, Michel Bottlaender, (unknown), Denis Le Bihan	13
7	Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study 2023 ·Alzheimer s Research & Therapy ·Julien Lagarde, (unknown), Mattéo Tonietto, S. Rodrigo, Philippe Gervais, Fabien Caillé, (unknown), Michel Bottlaender, Marie Sarazin	8
8	Positron Emission Tomography with [¹⁸F]‐DPA‐714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression 2023 ·Annals of Neurology ·(unknown), (unknown), Giacomo Boffa, Andrea Lazzarotto, Martina Absinta, Vito A. G. Ricigliano, (unknown), Mattéo Tonietto, Philippe Gervais, Anne Bissery, Céline Louapre, Michel Bottlaender, Benedetta Bodini, Bruno Stankoff	38
9	A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Claire Leroy, Sébastien Goutal, (unknown), Philippe Gervais, (unknown), Philippe Ciuciu, Sylvain Auvity, Dominique Vodovar, Claude Comtat, Vincent Lebon, Michel Bottlaender, Nicolas Tournier	1
10	Characterization of altered neuroenergetic patterns in Alzheimer’s Disease using combined FDG‐PET and sodium MRI 2023 ·Alzheimer s & Dementia ·(unknown), (unknown), Sandro Romanzetti, Michel Bottlaender, Fawzi Boumezbeur, Julien Lagarde, (unknown), Florian Holtbernd, Marie Sarazin, Oliver Winz, Alexander Heinzel, Felix M. Mottaghy, Jörg B. Schulz, Kathrin Reetz	1
11	Impact of Donepezil on Brain Glucose Metabolism Assessed Using [18F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide 2022 ·Frontiers in Neuroscience ·(unknown), Sébastien Goutal, Marie Sarazin, Michel Bottlaender, Fabien Caillé, (unknown), Mathieu Charvériat, Alexandra Winkeler, Nicolas Tournier	7
12	Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation 2021 ·Radiology ·Vito A. G. Ricigliano, Emanuele Morena, Annalisa Colombi, Mattéo Tonietto, (unknown), Émilie Poirion, Michel Bottlaender, Philippe Gervais, Céline Louapre, Benedetta Bodini, Bruno Stankoff	112
13	Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type 2021 ·Translational Psychiatry ·Julien Lagarde, (unknown), Mattéo Tonietto, Philippe Gervais, Claude Comtat, Fabien Caillé, Michel Bottlaender, Marie Sarazin	9
14	Idiopathic Normal-Pressure Hydrocephalus: Diagnostic Accuracy of Automated Sulcal Morphometry in Patients With Ventriculomegaly 2019 ·Neurosurgery ·Grégory Kuchcinski, (unknown), Marc Baroncini, François Machuron, Hélène Behal, (unknown), Renaud Lopes, Christine Delmaire, Thibaud Lebouvier, Michel Bottlaender, Régis Bordet, Luc Defebvre, Jean‐Pierre Pruvo, X. Leclerc, Jérôme Hodel	6
15	[18F]-AV-1451 tau PET imaging in Alzheimer’s disease and suspected non-AD tauopathies using a late acquisition time window 2019 ·Journal of Neurology ·Julien Lagarde, (unknown), Fabien Caillé, Philippe Gervais, Jean‐Claude Baron, Michel Bottlaender, Marie Sarazin	9
16	Early alteration of the locus coeruleus in phenotypic variants of Alzheimer’s disease 2019 ·Annals of Clinical and Translational Neurology ·(unknown), Julien Lagarde, Stéphane Lehéricy, Romain Valabrègue, (unknown), (unknown), Fabien Caillé, Philippe Gervais, Michel Bottlaender, Marie Sarazin	50
17	Sulcal morphology in Alzheimer's disease: an effective marker of diagnosis and cognition 2019 ·Neurobiology of Aging ·Maxime Bertoux, Julien Lagarde, Fabian Corlier, Lorraine Hamelin, Jean‐François Mangin, Olivier Colliot, Marie Chupin, Meredith N. Braskie, Paul M. Thompson, Michel Bottlaender, Marie Sarazin	24
18	Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer’s disease patients 2015 ·Translational Psychiatry ·Fabian Corlier, Isabelle Rivals, Julien Lagarde, Lorraine Hamelin, Hélène Corne, Luce Dauphinot, Kunié Ando, Jack‐Christophe Cossec, Gaëlle Fontaine, Guillaume Dorothée, Catherine Malaplate‐Armand, (unknown), Bruno Dubois, Michel Bottlaender, Charles Duyckaerts, Marie Sarazin, Marie‐Claude Potier, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	18
19	Assessment of myelin content by positron emission tomography with [methyl-C-11]-2-(4 '-methylaminophenyl)-6-hydroxybenzothiazole in relapsing-remitting MS 2012 ·UCL Discovery (University College London) ·Benedetta Bodini, Laure Bottin, Léorah Freeman, Audrey Chardain, Marco Battaglini, Olga Ciccarelli, Caroline Papeix, Damien Galanaud, Bernard Zalc, Daniel García-Lorenzo, Stéphane Lehéricy, Catherine Lubetzki, Michel Bottlaender, Bruno Stankoff	1
20	Radiosynthesis and biodistribution of two potential antagonists of cerebral histamine H3 receptors for PET studies: [18F]FUB 272 and [11C]UCL 1829 1998 ·UCL Discovery (University College London) ·(unknown), Stéphane Demphel, Chantal Fuseau, (unknown), Michel Bottlaender, (unknown), Holger Stark, Walter Schunack, (unknown), C. Robin Ganellin, C. Crouzel	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact